What peptides these deltorphins be

Progress in Neurobiology

Volumn 57, Issue 4, 1999, Pages 377-420

  Lazarus, Lawrence H ^a,b   Bryant, Sharon D ^a   Cooper, Peter S ^a   Salvadori, Severo ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DELTA OPIATE RECEPTOR AGONIST; DELTORPHIN;

AMINO ACID COMPOSITION; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ENANTIOMER; FROG; LIGAND BINDING; MOLECULAR CLONING; NONHUMAN; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANIMALS; ANURA; BINDING SITES; HUMANS; NARCOTICS; OLIGOPEPTIDES; PROTEIN CONFORMATION; RECEPTORS, OPIOID, DELTA; SECOND MESSENGER SYSTEMS;

EID: 0032928689     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(98)00050-1     Document Type: Review

References (408)

1. 2]deltorphin I and its immunohistochemical application to the mouse brain. NeuroReport. 3:1992;669-672.
2. Alkorta I., Lowe G. H. A 3D model of the δ opioid receptor and ligand-receptor complexes. Prot. Engnr. 9:1996;573-583.
3. 2): a potent and fully specific agonist for the δ-opioid receptor. Mol. Pharmac. 35:1989;774-779.
4. Amodeo P., Motta A., Tancredi T., Salvadori S., Tomatis R., Picone D., Saviano G., Temussi P. Solution structure of deltorphin I at 265 K: a quantitative NMR study. Pept. Res. 5:1992;48-55.
5. 9]-antamanide analogs. J. Peptide Res. 51:1998;180-187.
6. Arden J. R., Segredo V., Wang Z., Lameh J., Sadee W. Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged μ-opioid receptor expressed in HEK 293 cells. J. Neurochem. 65:1995;1636-1644.
7. + channels and cAMP in opioid-induced pial artery dilation. Brain Res. 747:1997;252-258.
8. Attila M., Salvadori S., Balboni G., Bryant S. D., Lazarus L. H. Synthesis and receptor binding analysis of dermorphin hepta-, hexa- and pentapeptide analogues. Evidence for one- and two-site binding models for the μ-opioid receptor. Int. J. Pept. Prot. Res. 42:1993;550-559.
9. Attila M., Bryant S. D., Lazarus L. H., Salvadori S. Mechanism of recovery of down-regulated opioid receptors in various neuroblastoma cells. Can. J. Physiol. 72(Sup. 1):1994;526.
10. Balboni G., Marastoni M., Picone D., Salvadori C., Tancredi T., Temussi P., Tomatis R. New features of the δ opioid receptor: conformational properties of deltorphin I analogues. Biochem. Biophys. Res. Commun. 169:1990;617-622.
11. Balboni G., Salvadori S., D'Angeli F., Marchetti P., Lazarus L. H., Bryant S. D., Bianchi C. Single diastereomeric desaminotyrosylalanyl tetra- and heptapeptides with opioid antagonistic activity. Int. J. Pept. Prot. Res. 45:1995;187-193.
12. Balboni G., Guerrini R., Salvadori S., Tomatis R., Bryant S. D., Bianchi C., Attila M., Lazarus L. H. Opioid diketopiperazines: synthesis and activity of a prototypic class of opioid antagonists. Biol. Chem. 378:1997;19-29.
13. Baldwin, J. M. (1993) The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12, 1693-1703.
14. Bare L., Mansson E., Yang D. Expression of two variants of the human μ opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett. 354:1994;213-216.
15. 2]Deltorphin, a 17 amino acid opioid peptide from the skin of the Brazilian hylid frog, Phyllomedusa burneisteri. Peptides. 15:1994;199-202.
16. Barthalmus G. T., Zielinski W. J. Xenopus skin mucus induces oral dyskinesia that promote escape from snakes. Biochem. Behav. 30:1988;957-959.
17. Befort K., Tabbara L., Bausch S., Chavkin C., Evans C., Kieffer B. The conserved aspartate residue in the third putative transmembrane domain of the δ opioid receptor is not the anionic counterpart for cationic opiate binding but is a constituent of the receptor binding site. Mol. Pharmac. 49:1996;216-223.
18. Befort K., Tabbara L., Kling D., Maigret B., Kieffer B. Role of aromatic transmembrane residues of the δ-opioid receptor in ligand recognition. J. Biol. Chem. 271:1996;10161-10168.
19. Belkowski S., Zhu J., Liu-Chen L., Eisenstein T., Alder M., Rogers T. Sequence of κ-opioid receptor cDNA in the R1.1 thymoma cell line. J. Neuroimmun. 62:1995;113-117.
20. Benyhe S. Morphine: new aspects in the study of an ancient compound. Life Sci. 55:1994;969-979.
21. 4]deltorphin II in mice. Peptides. 18:1997;1609-1613.
22. 2-opioid receptor agonist in mice. Brain Res. 719:1996;56-61.
23. Bian J.-T., Bhargava H. N. Effects of morphine-3-glucuronide on the antinociceptive activity of peptide and nonpeptide opioid receptor agonists in mice. Peptides. 17:1996;1415-1419.
24. Bilsky E. J., Montegut M. J., Delong C. L., Reid L. D. Opioidergic modulation of cocaine conditioned place preferences. Life Sci. 50:1992;PL85-90.
25. Bilsky E., Bernstein R., Pasternak G., Hruby V., Patel D., Porreca F., Lai J. Selective inhibition of [D-Ala,Glu]deltorphin antinociception by supraspinal but not spinal administration of an antisense oligodeoxynucleotide to an opioid delta receptor. Life Sci. 55:1994;PL37-43.
26. Bilsky E., Bernstein R., Hruby V., Rothman R., Lai J., Porreca F. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide mediated "knock-down" of opioid receptors in vivo. J. Pharmac. exp. Ther. 277:1996;491-501.
27. Blalock J. E., Smith E. M. A complete regulatory loop between the immune and neuroendocrine systems. Fed. Proc. 44:1985;108-111.
28. Bloom F. E. Neuropeptides and other mediators in the central nervous system. J. Immun. 135:1985;743s-745s.
29. Bondanelli, M., Ambrosio, M. R., Valentini, A. and degli Uberti, E. C. (1998) Effect of δ-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women. Human Reproduc. 13, 1159-1162.
30. Breveglieri A., Guerrini R., Salvadori S., Bianchi C., Bryant S. D., Attila M., Lazarus L. H. Design and synthesis of 1-aminocycloalkane-1-carboxylic acid-substituted deltorphin analogues: unique δ and μ opioid activity in modified peptides. J. Med. Chem. 39:1996;773-780.
31. Broccardo M., Improta G. Antidiarrheal effect of deltorphin II, a highly selective delta opioid receptor agonist, in the rat. Pharmac. Res. 25:1992;5-6.
32. 2]deltorphin II, in the rat. Eur. J. Pharmac. 218:1992;69-73.
33. Broccardo M., Improta G. Central antidiarrheal and colonic antipropulsive effects of D-Ala-deltorphin II, a selective delta opioid agonist in the mouse. Pharmac. Res. 25:1992;275-276.
34. Broccardo M., Improta G. Hypothermic effect of D-Ala-deltorphin II, a selective δ opioid receptor agonist. Neurosci. Lett. 139:1992;209-212.
35. Brown M., Rivier J. E., Vale W. Bombesin: potent effects on thermoregulation in the rat. Science. 196:1977;998-1000.
36. Bryant H. U., Bernton E. W., Holaday J. W. Immunosuppressive effects of chronic morphine treatment in mice. Life Sci. 41:1987;1731-1738.
37. Bryant S. D., Salvadori S., Attila M., Lazarus L. H. Topographical conformations of the deltorphins predicate δ opioid receptor affinity. J. Am. Chem. Soc. 115:1993;8503-8504.
38. Bryant S. D., Attila M., Salvadori S., Guerrini R., Lazarus L. H. Molecular dynamics conformations of deltorphin analogues advocate δ opioid binding site models. Peptide Res. 7:1994;175-184.
39. Bryant S. D., Balboni G., Guerrini R., Salvadori S., Tomatis R., Lazarus L. H. Opioid diketopiperazines: refinement of the δ opioid antagonist pharmacophore. Biol. Chem. 378:1997;107-114.
40. Bryant S. D., Guerrini R., Salvadori S., Bianchi C., Tomatis R., Attila M., Lazarus L. H. Helix inducing α-aminoisobutyric acid in opioidmimetic deltorphin C analogues. J. Med. Chem. 40:1997;2579-2587.
41. Bryant S. D., Salvadori S., Cooper P. S., Lazarus L. H. New δ opioid antagonists as pharmacological probes. Trends Pharmac. Sci. 19:1998;42-46.
42. 3H]deltorphin II. Life Sci. 50:1991;Pl75-Pl78.
43. Buzas B., Izenwasser S., Portoghese P. S., Cox B. M. Evidence for delta opioid receptor subtypes regulating adenylyl cyclase activity in rat brain. Life Sci. 54:1994;101-106.
44. Cahill C. M., White T. D., Sawynok J. Synergy between μ/δ-opioid receptors mediates adenosine release from spinal cord synaptosomes. Eur. J. Pharmac. 298:1996;45-49.
45. 3H]DPDPE binding. Eur. J. Pharmac. 335:1997;161-166.
46. Capasso A., Amodeo P., Balboni G., Guerrini R., Lazarus L. H., Temussi P. A., Salvadori S. Design of μ selective opioid dipeptide antagonists. FEBS Lett. 417:1997;141-144.
47. Castiglione-Morelli M. A., Lelj F., Pastore A., Salvadori S., Tancredi T., Tomatis R., Trivellone E., Temussi P. A. A 500-MHz proton nuclear magnetic resonance study of μ opioid peptides in a simulated receptor environment. J. Med. Chem. 30:1987;2067-2073.
48. 5] enkephalin-dermenkephalin chimeric peptides. Life Sci. 49:1991;495-503.
49. Ceusters M., Tourwé D., Callaerts J., Mertens J., Peter A. New single-step radioiodination technique for peptides: Cu(I)-catalyzed nucleophilic nonisotopic displacement reaction. Synthesis of radioiodinated deltorphin and dermorphin analogues. J. Org. Chem. 60:1995;8324-8326.
50. Chang K.-J., Rigdon G. C., Howard J. L., McNutt R. W. A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86. J. Pharmac. exp. Ther. 267:1993;852-857.
51. Charpentier S., Sagan S., Delfour A., Nicolas P. Dermenkephalin and deltorphin I reveal similarities within ligand binding domains of μ and δ opioid receptors and an additional address subsite on the δ-receptor. Biochem. Biophys. Res. Commun. 179:1991;161-1168.
52. Charpentier S., Sagan S., Naim M., Delfour A., Nicolas P. Mechanism of δ-opioid receptor selection by the address domain of dermenkephalin. Eur. J. Pharm. 266:1994;175-180.
53. Chen Y., Mestek A., Liu J., Yu L. Molecular cloning of a rat κ opioid receptor reveals sequence similarities to the μ and δ opioid receptors. Biochem. J. 295:1993;625-628.
54. 2]deltorphin I. Eur. J. Pharmac. 230:1993;85-88.
55. Chiba T., Murase H., Ambo A., Sasaki Y. Antinociceptive activity of deltorphin analogs in the formalin test. Life Sci. 59:1996;1717-1723.
56. Chuman, Y., Yasunaga, T., Costa, T. and Shimohigashi, Y. (1997) Discrimination of a novel type of rat brain δ-opioid receptors by enkephalin analog containing structurally constrained cyclopropylphenylalanine (ΔPHE). Biochem. Mol. Biol. Internatl. 42, 1227-1233.
57. Churchill L., Kaalivas P. W. Dopamine depletion produces augmented behavioral responses to mu, but not a delta-opioid agonist in the nucleus accumbens. Synapse. 11:1992;47-57.
58. 1 and δ opioid receptors. Psychopharmacology. 120:1995;347-355.
59. Clark M. J., Emmerson P. J., Mansour A., Akil H., Woods J. H., Portoghese P. S., Remmers A. E., Medzihradsky F. Opioid efficacy in a C6 glioma cell line stably expressing the delta opioid receptor. J. Pharmac. exp. Ther. 283:1997;501-510.
60. Claude P. A., Wotta D. R., Zhang X. H., Prather P. L., McGinn T. M., Erickson L. J., Loh H. H., Law P. Y. Mutation of a conserved serine in TM4 of opioid receptors confers full agonistic properties to classical antagonists. Proc. natl Acad. Sci. U.S.A. 93:1996;5715-5719.
61. Collin E., Mauborgne A., Bourgoin S., Chantrel D., Hamon M., Cesselin F. In vivo tonic inhibition of spinal substance P (-like material) release by endogenous opioid(s) acting at δ receptors. Neuroscience. 44:1991;725-731.
62. 2+ channel currents of acutely dissociated rat periaqueductal grey neurons. J. Physiol 509, 47-58.
63. Connor M. A., Keir M. J., Henderson G. δ-opioid receptor mobilization of intracellular calcium in SH-SY5Y cells: lack of evidence for δ-receptor subtypes. Neuropharmacology. 36:1997;125-133.
64. Cotton R., Giles M. G., Miller L., Shaw J. S., Timms D. ICI 174864: a highly selective antagonist for the opioid δ-receptor. Eur. J. Pharmac. 97:1984;331-332.
65. Crescenzi O., Amodeo P., Cavicchioni G., Guerrini R., Picone D., Salvadori S., Tancredi T., Temussi P. A. δ-Selective opioid peptides containing a single aromatic residue in the message domain: an NMR conformational analysis. J. Peptide Sci. 2:1996;290-308.
66. Crescenzi O., Fraternali F., Picone D., Tancredi T., Balboni G., Guerrini R., Lazarus L. H., Salvadori S., Temussi P. A. Design and solution structure of a partially rigid opioid antagonist lacking the basic center. Eur. J. Biochem. 247:1997;66-73.
67. Crook T. J., Kitchen I., Hill R. G. Effects of the δ-opioid receptor antagonist naltrindole on antinociceptive responses to selective δ-agonists in post-weanling rats. Br. J. Pharmac. 107:1992;573-576.
68. Cucumel K., Cupo A. Anti-idiotypic antibodies: a useful alternative for studying the biochemical expression of μ/δ opioid binding sites in mammalian brain. J. Neuroimmun. 62:1995;183-195.
69. Cucumel K., Garreau I., Mery J., Moinier D., Mansour A., Akil H., Cupo A. Production and characterization of site-directed antibodies against dermorphin and dermorphin-related peptides. Peptides. 17:1996;973-982.
70. Cvejic S., Devi L. A. Dimerization of the δ opioid receptor. Implication for a role in receptor internalization. J. Biol. Chem. 272:1997;26959-26964.
71. 353, located within the COOH-terminal tail of the δ opiate receptor, is involved in receptor down-regulation. J. Biol. Chem. 271:1996;4073-4076.
72. Daly J. W., Caceres J., Moni R. W., Gusovsky R., Moos J. M., Seamon K. B., Milton K., Myers C. W. Frog secretions and hunting magic in the upper Amazon: identification of a peptide that interacts with an adenosine receptor. Proc. natl Acad. Sci. U.S.A. 89:1992;10960-10963.
73. Darlison M. G., Greten F. R., Harvey R. J., Kreienkamp H.-J., Stühmer T., Zwiers H., Lederis K., Richter D. Opioid receptors from a lower vertebrate (Catostomus commersoni): sequence, pharmacology, coupling to a G-protein-gated invward-rectifying potassium channel (GIRK1) and evolution. Proc. natl Acad. Sci. U.S.A. 94:1997;8214-8219.
74. De Luca A., Coupar I. M. Insights into opioid action in the intestinal tract. Pharmac. Ther. 69:1996;103-115.
75. De Sarro G. B., Marra R., Spagnolo C., Nistico G. Delta opioid receptors mediate seizures produced by intrahippocampal injection of Ala-deltorphin in rats. Funct. Neurol. 7:1992;235-238.
76. De Sarro G. B., Spagnolo C., Audino M. G., Marra R., Nistico G. Comparative behavioural and ECoG spectrum of dermorphin and Ala-deltorphin given into some areas of the rat brain. Res. Commun. Subst. Abuse. 13:1992;147-165.
77. Dhwan B. H., Cesselin F., Raghubir R., Bradley B., Portoghese P., Hamon M. International union of pharmacology. XII. Classification of opioid receptors. Pharmac. Rev. 48:1996;567-592.
78. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. natl Acad. Sci. U.S.A. 85:1988;5274-5278.
79. Dougherty D. A. Cation-π interactions in chemistry and biology: a new view of benzene, Phe, Tyr, and Trp. Science. 271:1996;163-168.
80. 125I]Deltorphin-I: a new tool for the identification of delta-opioid receptors. In: New Leads in Opioid Research, pp. 218-220. Eds. J. M. van Ree, A. H. Mulder, V. M. Wiegant and T. B. van Wimersma Greidanus. Noodwijkerhout, Excerpta Medica, Amsterdam, The Netherlands.
81. 2] deltorphin-I: a high affinity, delta-selective opioid receptor ligand. Peptides. 12:1991;825-830.
82. Elliott J., Traynor J. R. Evidence for lack of modulation of μ-opioid agonist action by δ-opioid agonists in the mouse vas deferens and guinea-pig ileum. Br. J. Pharmac. 114:1995;1064-1068.
83. Emmerson, P. J., Liu, M.-R., Woods, J. H. and Medzihradsky, F. (1994) Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J. Pharmac. exp. Ther. 271, 1630-1637.
84. Erspamer V. The tachykinin peptide family. Trends Neurosci. 4:1981;267-269.
85. Erspamer V. Half a century of comparative research on biogenetic amines and active peptides in amphibian skin and molluscan tissues. Comp. Biochem. Physiol. 79C:1984;1-7.
86. Erspamer V. The opioid peptides of the amphibian skin. Int. J. Dev. Neurosci. 10:1992;3-30.
87. Erspamer, V. (1994) Bioactive Secretions of the Amphibian Integument. Surry Beatty and Sons, Clipping North.
88. Erspamer V., Melchiorri P. Active polypeptides of the amphibian skin and their synthetic analogues. Pure Appl. Chem. 35:1973;463-494.
89. Erspamer V., Bertaccini G., Cei J. M. Occurrence of an eledoisin-like polypeptide (physalaemin) in skin extracts of Physalaemus fuscumaculatus. Experientia. 18:1962;562-563.
90. Erspamer V., Bertaccini G., Cei J. M. Occurrence of bradykinin-like substances in the amphibian skin. Experientia. 18:1962;563-564.
91. Erspamer, V., Erspamer, G. and Negri, L. (1974) Naturally occurring kinins. In: Chemistry and Biology of the Kallikrein-Kinin System in Heal and Disease, pp. 153-164. Eds. J. Pisano and K. Austen. DHEW Publishing.
92. Erspamer V., Melchiorri P., Broccardo M., Erspamer G., Falaschi P., Improta G., Negri L., Renda T. The brain-gut-skin triangle: new peptides. Peptides. 2:1981;7-16.
93. Erspamer V., Erspamer G., Mazzanti G., Endean R. Active peptides in the skins of one hundred amphibian species from Australia and Papua New Guinea. Comp. Biochem. Physiol. 77C:1984;99-108.
94. Erspamer V., Erspamer G., Melchiorri P., Mazzanti G. A potent factor in extracts of the skin of the Australian frog, Pseudophryne coriacea. Apparent facilitation of transmitter release in isolated smooth muscle preparations. Neuropharmacology. 24:1985;783-792.
95. Erspamer V., Melchiorri P., Erspamer G., Montecucchi P., de Castiglione R. Phyllomedusa skin: a huge factory and store-house of a variety of active peptides. Peptides. 6:1985;7-12.
96. Erspamer V., Erspamer G., Cei J. Active peptides in the skins of two hundred and thirty American amphibian species. Comp. Biochem. Physiol. 85C:1986;125-137.
97. Erspamer V., Melchiorri P., Erspamer G., Negri L., Corsi R., Severini C., Barra D., Simmaco M., Kreil G. Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for δ opioid binding sites. Proc. natl Acad. Sci. U.S.A. 86:1989;5188-5192.
98. Erspamer V., Falconieri Erspamer G., Severini C., Potenza R., Barra D., Mignogna G., Bianchi A. Pharmacological studies of "SAPO" from the frog Phyllomedusa bicolor skin: a drug used by the Peruvian Matses Indians in shamanic hunting practices. Toxicon. 31:1993;1089-1111.
99. Evans C. J., Keith J. D. E., Morrison H., Magendzo K., Edwards R. H. Cloning of a delta opioid receptor by functional expression. Science. 258:1992;1952-1955.
100. Faith R. E., Plotnikoff N. P., Murgo A. J. Effects of opiates and neuropeptides on immune functions. NIDA Monogr. 54:1984;300-311.
101. Falconieri Erspamer G., Severini C. Guinea-pig ileum (GPI) and mouse vas deferens (MVD) preparations in the discovery, discrimination and parallel bioassay of opioid peptides. Pharmac. Res. 26:1992;109-121.
102. + currents in F11 neuroblastoma x DRG neuron hybrid cells via cholera toxin-sensitive receptors. Brain Res. 605:1993;214-220.
103. 4] deltorphin and characterization of its δ opioid receptor binding properties. Life Sci. 51:1992;189-193.
104. Fiori A., Cardelli P., Negri L., Savi M. R., Strom R., Erspamer V. Deltorphin transport across the blood-brain barrier. Proc. natl Acad. Sci. U.S.A. 94:1997;9469-9474.
105. 5] enkephalin, a highly potent, δ opioid receptor-selective compound: comparison with proposed solution conformations. J. Am. Chem. Soc. 116:1994;7523-7531.
106. Fontani G., Vergnani L., Salvadori S., Voglino N., Aloisi A. M., Portaluppi F., Degli Uberti E. C. Effect of deltorphin on behavior and hippocampal electrical activity in rabbits. Physiol. Behav. 53:1993;285-290.
107. Froehlich, J. C. and Li, T.-K. (1993) Opioid peptides. Plenum Press, New York.
108. Froehlich, J. C., Wand, G., Charness, M., Chiara, G. and Koob, G. (1996) The neurobiology of ethanol-opioid interactions in ethanol reinforcement. Alcoholism: Clin. exp. Res. 20, A181-A186.
109. 2]deltorphin I-like immunoreactivity in mucosal epithelial cells of rat gastrointestinal tract. Peptides. 15:1994;1095-1100.
110. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H. Primary structures and expression from cDNAs of rat opioid receptor δ- and μ-subtypes. FEBS Lett. 327:1993;311-314.
111. Gacel G. A., Fellion E., Baamonde A., Dauge V., Roques B. P. Synthesis, biochemical and pharmacological properties of BUBUC, a highly selective and systemically active agonist for in vivo studies of δ-opioid receptors. Peptides. 11:1990;983-988.
112. Galligan J. J., Mosberg H. I., Hurst R., Hruby V. J., Burks T. F. Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids. J. Pharmac. exp. Ther. 229:1984;641-648.
113. Garzon J., Castro M., Juarros J., Blazquez P. Antibodies raised against the n-terminal sequence of δ opioid receptors blocked δ-mediated supraspinal antinociception in mice. Life Sci. 54:1994;PL191-196.
114. x/z transducer proteins in mouse periaqueductal gray matter. J. Pharmac. exp. Ther. 281:1997;549-557.
115. Gaudriault G., Nouel D., Dal Farra C., Beaudet A., Vincent J.-P. Receptor-induced internalization of selective peptidic μ and δ opioid ligands. J. Biol. Chem. 272:1997;2880-2888.
116. Gaudriault G., Zsurger N., Vincient J.-P. Preparation and binding properties of radioiodinated analogues of dermorphin and deltorphin with high specificity for the μ- and δ-opioid receptors. J. Neurochem. 68:1997;813-819.
117. Gaveriaux-Ruff C., Peluso J., Befort K., Simonin F., Zilliox C., Kieffer B. L. Detection of opioid receptor mRNA by PT-PCR reveals alternative splicing for the δ- and κ-opioid receptors. Mol. Brain Res. 48:1997;298-304.
118. Gioanni Y., Goyon D., Prevost J. Intracerebroventricular dermorphin, but not dermenkephalin, is epileptogenic in rat. NeuroReport. 2:1991;49-52.
119. Goodman M., Ro S., Osapay G., Yamazaki T., Polinsky A. The molecular basis of opioid potency and selectivity: morphiceptins, dermorphins, deltorphins, and enkephalins. NIDA Res. Monogr. 143:1993;195-209.
120. 1]deltorphin B. Eur. J. Pharm. 302:1996;37-42.
121. Guerrini R., Capasso A., Marastoni A., Bryant S. D., Cooper P. S., Lazarus L. H., Temussi P. A., Salvadori S. Rational design of dynorphin A analogues with δ-receptor selectivity and antagonism for δ- and κ-receptors. Bioorg. Med. Chem. 6:1998;57-62.
122. Guis C., Bruetschy L., Meudal H. P. R. B., Gacel G. Investigation of the structural parameters involved in the δ-opioid selectivity of several families of opioid peptides. Int. J. Pept. Prot. Res. 41:1993;576-586.
123. Gyires K. A. Z. R., Tóth G., Darula Z., Furst S. Analysis of the role of delta opioids receptors in gastroprotection in the rat. Life Sci. 60:1997;1337-1347.
124. Hazum E., Chang K.-J., Cuatrecasas P. Opiate (enkephalin) receptors of neuroblastoma cells: occurrence in clusters on the cell surface. Science. 206:1979;1077-1079.
125. Heidbreder C., Shoaib M., Shippenberg T. S. Differential role of δ-opioid receptors in the development and expression of behavioral sensitization to cocaine. Eur. J. Pharmac. 298:1996;207-216.
126. Herz A. Endogenous opioid systems and alcohol addiction. Psychopharmacology. 129:1997;99-111.
127. Herz, A. (1998) Opioid reward mechanisms: a key role in drug abuse? Can. J. Pharmac. 76, 252-258.
128. 3 aromatic moiety in delta receptor selective dermorphin/deltorphin-related tetrapeptides. Int. J. Pept. Prot. Res. 39:1992;450-457.
129. 3 aromatic ring in cyclic δ opioid receptor-selective dermorphin/deltorphin tetrapeptide analogues: electronic and lipophilic requirements for receptor affinity. J. Med. Chem. 35:1992;1535-1541.
130. Heyl D. L., Schullery S. E. Developments in the structure-activity relationships for the δ-selective opioid peptides of amphibian skin. Current Med. Chem. 4:1997;117-150.
131. 3 residue in the δ-selective opioid peptide deltorphin I: effects on binding affinity and selectivity. Int. J. Pept. Prot. Res. 44:1994;420-426.
132. Heyl D. L., Bouzit H., Mousigian C. Structural requirements for binding to the δ opioid receptor: alkyl replacements at the third residue of deltorphin I. Lett. Peptide Sci. 2:1995;277-284.
133. 3 replacement with ring-substituted and heterocyclic amino acids. J. Med. Chem. 38:1995;1242-1246.
134. Hill, K. G. and Kiefer, S. W. (1997) Naltrexone treatment increases the aversiveness of alcohol for outbred rats. Alcoholism: Clin. exp. Res. 21, 637-641.
135. 1- but not by a δ-opioid receptor antagonist in alcohol-preferring rats. Eur. J. Pharmac. 304, 7-13.
136. 4]-substituted derivatives: further evidence of opioid delta receptor multiplicity. J. Pharmac. exp. Ther. 265:1993;896-902.
137. Hruby V. J., Gehrig C. Recent developments in the design of receptor specific opioid peptides. Med. Res. Rev. 9:1989;343-401.
138. 2]deltorphin II, a novel and highly selective delta-opioid receptor agonist. Peptides. 13:1992;1123-1126.
139. 2 opioid receptor agonists on gastric functions in the rat. Neuropharmacology. 33:1994;977-981.
140. Iuvone T., Capasso A., D'Acquisto F., Carnuccio R. Opioids inhibit the induction of nitric oxide synthase in J774 macrophages. Biochem. Biophys. Res. Commun. 212:1995;975-980.
141. Iwasaki Y., Kawahara T., Shimoi H., Suzuki K., Ghisalba O., Kangawa K., Matsuo H., Nishikawa Y. Purification and cDNA cloning of Xenopus laevis skin peptidylhydroxyglycine N-C lyase, catalyzing the second reaction of C-terminal α-amidation. Eur. J. Biochem. 201:1991;551-559.
142. Izenwasser S., Buzas B., Cox B. M. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens. J. Pharmac. exp. Ther. 267:1993;145-152.
143. Jacobson A., Gintzler A., Sayre L. Minimum-structure enkephalin analogues incorporating L-tyrosine, D (or L) phenylalanine, and a diamine spacer. J. Med. Chem. 32:1989;1708-1717.
144. Jhamandas, K. H., Sutak, M. and Henderson, G. (1998) Antinociceptive and morphine modulatory actions of spinal oprhanin FQ. Can. J. Pharmac. 76, 314-324.
145. Ji H., Zhang R., Hu X., Lai L., Xu X. Synthesis, conformation and opioid activity of deltorphins. Biochem. Biophys. Res. Commun. 207:1995;99-104.
146. 2]deltorphin II, a highly selective δ agonist in vivo. Life Sci. 47:1990;PL43-47.
147. Jiang Q., Takemori A., Sultana M., Portoghese P., Bowen W., Mosberg H. I., Porreca F. Differential antagonism of opioid delta antinociception by [D-Ala,Leu,Cys]enkephalin and naltrindole 5′-isothiocynate: evidence for delta receptor subtypes. J. Pharmac. exp. Ther. 257:1991;1069-1075.
148. Jones, L. S., Grooms, S. Y., Salvadori, S. and Lazarus, L. H. (1991) Effect of μ- and δ-Opioid Agonists on Schaffer Collateral and Mossy Fiber Evoked Responses in CA1 and CA3 of Hippocampal Slice. Society for Neuroscience, New Orleans, LA.
149. Jones L. S., Grooms S. Y., Salvadori S., Lazarus L. H. Dermorphin-induced hyperexcitability in hippocampal CA3 and CA1 in vitro. Eur. J. Pharmac. 264:1994;39-48.
150. 1-opioid receptor antagonism in the antitussive effect of δ-opioid receptor antagonists. Eur. J. Pharmac. 251:1994;291-294.
151. Kamphuis, S., Driksson, F., Kavelaars, A., Zijlstra, J., van de Pol, M., Kuis, W. and Heijnen, C. J. (1998) Role of endogenous pro-enkephalin A-derived peptides in human T cell proliferation and monolcyte IL-6 production. J. Neuroimmunol. 84, 53-60.
152. Kenakin T. The classification of seven transmembrane receptors in recombinant expression systems. Pharmac. Rev. 48:1996;413-463.
153. Kest B., Lee C., McLemore G., Inturrisi C. An antisense oligodeoxynucleotide to the delta opioid receptor (DOR-1) inhibits morphine tolerance and acute dependence in mice. Brain Res. Bull. 39:1996;185-188.
154. Kest B., Lee C. E., Mogil J. S., Inturrisi C. E. Blockade of morphine supersensitivity by the antisense oligodeoxynucleotide targeting the delta opioid receptor (DOR-1). Life Sci. 60:1997;155-159.
155. Kest, B., Lee, C. E., Jenab, S., Kao, B. and Inturrisi, C. E. (1998) Chronic naltrexone differentially affects supraspinal δ-opioid receptor-mediated antinociception. Eur. J. Pharmac. 345, 47-53.
156. Kieffer, B. L. (1997) Molecular aspect of opioid receptors. In The Pharmacology of Pain, pp. 281-303. Eds. A. Dickenson and J.-M. Besson. Springer, Berlin.
157. Kieffer B. L., Befort K., Gaveriaux-Ruff C., Hirth G. C. The δ-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization. Proc. natl Acad. Sci. U.S.A. 89:1992;12048-12052.
158. 32P-Labeled opioid peptides with high affinity for the δ-opioid receptor. Anal. Biochem. 215:1993;1-8.
159. Kiss G., Michl H. Uber das giftsekret der gelbbauchunke, Bombina variegata L. Toxicon. 1:1962;33-39.
160. Knapp R. J., Yamamura H. I. Delta opioid receptor radioligands. Biochem. Pharmac. 44:1992;1687-1695.
161. Koch, T., Schulz, S., Schroder, H., Wolf, R., Raulf, E. and Hollt, V. (1998) Carboxyl-terminal splicing of the rat μ-opioid receptor modulates agonist-mediated internalization and receptor resensitization. J. Biol. Chem. 273, 13652-13657.
162. Kong H., Raynor K., Yasuda K., Moe S. T., Portoghese P. S., Bell G. I., Reisine T. A single residue, aspartic acid 95, in the δ opioid receptor specifies selective high affinity agonist binding. J. Biol. Chem. 268:1993;23055-23058.
163. Kosterlitz H. W., Watt A. J. Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone). Br. J. Pharmac. Chemother. 33:1968;266-276.
164. Kramer T. H., Davis P., Hruby V. J., Burks T. F., Porreca F. In vitro potency, affinity and agonist efficacy of highly selective delta opioid receptor ligands. J. Pharmac. exp. Ther. 266:1993;577-584.
165. Kreil G. Processing of precursors by dipeptidylaminopeptidases: a case of molecular ticketing. Trends Biochem. Sci. 1:1990;23-25.
166. Kreil G. Peptides containing a D-amino acid from frog and molluscs. J. Biol. Chem. 269:1994;10967-10970.
167. Kreil G. D-Amino acids in animal peptides. A. Rev. Biochem. 66:1997;337-345.
168. Kreil G., Barra D., Simmaco M., Erspamer V., Erspamer G., Negri L., Severini C., Corsi R., Melchiorri P. Deltorphin, a novel amphibian skin peptide with high selectivity and affinity for δ opioid receptors. Eur. J. Pharmac. 162:1989;123-128.
169. 2-opioid receptor antagonist nalriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmac. Biochem. Behav. 52, 153-159.
170. 2-agonist antinociception. NeuroReport. 5:1994;1049-1052.
171. Law S. F., Resine T. Changes in the association of G protein subunits with the cloned mouse delta opioid receptor on agonist stimulation. J. Pharmac. exp. Ther. 281:1997;1476-1486.
172. Law P., McGinn T., Wick M., Erickson L., Evans C., Loh H. Analysis of delta-opioid receptor activities stably expressed in CHO cell lines: function of receptor density? J. Pharmac. exp. Ther. 271:1994;1686-1694.
173. Lazarus L. H., Attila M. The toad, ugly and venomous, wears yet a precious jewel in his skin. Prog. Neurobiol. 41:1993;473-507.
174. Lazarus L. H., Brown M. R., Perrin M. H. Mast cell binding of neurotensin. I. Iodination of neurotensin and characterization of the interaction of neurotensin with mast cell receptor sites. J. Biol. Chem. 252:1977;7174-7179.
175. Lazarus L. H., Guglietta A., Wilson W. E., Irons B. J., de Castiglione R. Dimeric dermorphin analogues as μ-receptor probes on rat brain membranes. Correlation between central μ-receptor potency and suppression of gastric acid secretion. J. Biol. Chem. 264:1989;314-362.
176. Lazarus L. H., Wilson W. E., de Castiglione R., Guglietta A. Dermorphin gene sequence peptide with high affinity and selectivity for δ-opioid receptors. J. Biol. Chem. 264:1989;3047-3050.
177. Lazarus L. H., Salvadori S., Santagada V., Tomatis R., Wilson W. E. Function of negative charge in the "address domain" of deltorphins. J. Med. Chem. 34:1991;1350-1359.
178. Lazarus L. H., Salvadori S., Tomatis R., Wilson W. E. Opioid receptor selectivity reversal in deltorphin tetrapeptide analogues. Biochem. Biophys. Res. Commun. 178:1991;110-115.
179. Lazarus L. H., Salvadori S., Balboni G., Tomatis R., Wilson W. E. Stereospecificity of amino acid side chains in deltorphin defines binding to opioid receptors. J. Med. Chem. 35:1992;1222-1227.
180. Lazarus L. H., Salvadori S., Grieco P., Wilson W. E., Tomatis R. Unique sequence in deltorphin C confers structural requirement for δ opioid receptor selectivity. Eur. J. Med. Chem. 27:1992;791-797.
181. Lazarus L. H., Salvadori S., Attila M., Grieco P., Bundy D. M., Wilson W. E., Tomatis R. Interaction of deltorphin with opioid receptors: molecular determinants for affinity and selectivity. Peptides. 14:1993;21-28.
182. Lazarus L. H., Bryant S. D., Attila M., Salvadori S. Frog skin opioid peptides: a case for environmental mimicry. Environ. Health Perspect. 102:1994;648-654.
183. Lazarus L. H., Bryant S. D., Salvadori S., Attila M., Jones L. S. Opioid infidelity: novel opioid peptides with dual high affinity for δ- and μ-receptors. Trends Neurosci. 19:1996;31-35.
184. Lazarus, L. H., Bryant, S. D., Cooper, P. S., Guerrini, R., Balboni, G. and Salvadori, S. (1998) Design of δ-opioid peptide antagonists for emerging drug applications. Drug Disc. Today. 3, 284-294.
185. Lee C. E., Kest B., Jenab S., Inturrisi C. E. Effect of supraspinal antisense oligodeoxynucleotide treatment on δ-opioid receptor mRNA levels in mice. Mol. Brain Res. 48:1997;17-22.
186. 1-dependent stereotypies and stimulation of dopamine release in the nucleus accumbens. J. Neurosci. 11:1991;1565-1576.
187. Losen P. T., Nemeroff C. B., Bissette G., Burnett G. B., Prange J. A. J., Lipton M. A. Neurotensin-induced hypothermia in the rat: structure-activity studies. Neuropharmacology. 17:1978;109-113.
188. Macht D. I. The history of opium and some of its preparations and alkaloids. J. Am. Med. Assoc. 64:1915;477-481.
189. Manfredi P. L., Chandler S. W., Patt R., Payne R. High-dose epidural infusion of opioids for cancer pain: cost issues. J. Pain Sympt. Manage. 13:1997;118-121.
190. Marastoni M., Tomatis R., Balboni G., Salvadori S., Lazarus L. H. On the degradation of the deltorphin peptides by plasma and brain homogenate. Farmaco. 46:1991;1273-1279.
191. Marastoni, M., Guerrini, R., Tomatis, R., Salvadori, S., Fogagnolo, M., Fantin, G., Lazarus, L. H. and Bryant, S. D. (1994) Conformational restriction of the methionine in a deltorphin A opioid peptide. In: Peptides 1994, pp. 706-707. Ed. H. L. S. Maia.
192. Marastoni M., Salvadori S., Balboni G., Scaranari V., Borea P. A., Tomatis A. Synthesis and opioid activity of tyrosine sulfate containing dermorphin and deltorphin peptides. Arzneim.-Forsch./Drug Res. 45:1995;116-119.
193. Marastoni, M., Guerrini, R., Balboni, G., Salvadori, S., Fantin, G., Fogagnolo, M., Lazarus, L. H. and Tomatis, R. (1998) Opioid deltorphin C analogues containing cis- or trans-2 or 3- or 4-aminocyclohexanecarboxylic acid residue. Arzeimittel-Forsch./Drug Res. in press.
194. Mason G. A., Nemeroff C. B., Luttinger D., Hatlely O. L., Prange J. A. J. Neurotensin and bombesin: differential effects on body temperature of mice after intracisternal administration. Reg. Peptides. 1:1980;53-60.
195. Mathlowitz E., Jacob J., Jong Y., Calino G., Chickering D., Chaturved P., Santos C., Vijayaraghavan K., Montgomery S., Bassett M., Morrell C. Biologically erodeable microspheres as potential oral drug delivery systems. Nature. 386:1997;410-412.
196. 2] deltorphin I-like immunity in prenatal rat small intestine. J. Histochem. Cytochem. 42:1994;1377-1381.
197. Matsuzawa, S., Suzuki, T., Misawa, M. and Nagase, H. (1998) Involvement of μ- and δ-opioid receptors in the ethanol-associated place preference in rats exposed to foot shock stress. Brain Res. 803, 169-177.
198. 2] deltorphin II in mice: evidence for delta receptor subtypes. J. Pharmac. exp. Ther. 258:1991;583-587.
199. Mayer P., Schulzeck S., Kraus J., Zimprach A., Hollt V. Promoter region and alternatively spliced exons of the rat μ-opioid receptor gene. J. Neurochem. 66:1996;2272-2278.
200. Mazumder S., Nath I., Dhar M. M. Immunomodulation of human T cell responses with receptor selective enkephalins. Immun. Lett. 35:1993;33-38.
201. Mecozzi, S., West, A. P. Jr and Dougherty, D. A. (1996) Cation-π interactions in aromatics of biological and medicinal interest: electrostatic potential surfaces as a useful qualitative guide. 93, 10566-10571.
202. Melchiorri P., Negri L. The dermorphin peptide family. Gen. Pharmac. 27:1996;1099-1107.
203. Melchiorri P., Negri L., Falconieri-Erspamer G., Severini C., Corsi R., Soaje M., Erspamer V., Barra D. Structure-activity relationships of the δ-opioid-selective agonists, deltorphins. Eur. J. Pharmac. 195:1991;201-207.
204. 2 in rats exposed to morphine. Proc. natl Acad. Sci. U.S.A. 89:1992;3696-3700.
205. Meng F., Xie G.-X., Thompson R. C., Mansour A., Goldstein A., Watson S. L., Akil H. Cloning and pharmacological characterization of a rat κ opioid receptor. Proc. natl Acad. Sci. U.S.A. 90:1993;9954-9958.
206. Menkens K., Bilsky E., Wild K., Portoghese P. S., Reid L., Porreca F. Cocaine place preference is blocked by the δ-opioid receptor antagonist, naltrindole. Eur. J. Pharmac. 219:1992;345-346.
207. Merkouris M., Dragatsis I., Megaritis G., Konidakis G., Zioudrou C., Milligan G., Georgoussi Z. Identification of the critical domains of the δ-opioid receptor involved in G protein coupling using site-specific synthetic peptides. Mol. Pharmac. 50:1996;985-992.
208. Metzger T. G., Ferguson D. M. On the role of extracellular loops of opioid receptors in conferring ligand selectivity. FEBS Lett. 375:1995;1-4.
209. Minami M., Satoh M. Molecular biology of the opioid receptors: structures, functions and distributions. Neurosci. Res. 23:1995;121-125.
210. 5]enkephalin from binding to the δ opioid receptor. Mol. Pharmac. 50:1996;1413-1422.
211. Misicka A., Lipkowski A. W., Fang L., Knapp R. J., Davis P., Kramer T., Burks T. F., Yamamura H. I., Carr D. B., Hruby V. J. Topographical requirements for delta opioid ligands: presence of a carboxyl group in position 4 is not critical for deltorphin high delta receptor affinity and analgesic activity. Biochem. Biophys. Res. Commun. 180:1991;1287-1290.
212. Misicka A., Lipkowski A., Horvath R., Davis P., Kramer T., Yamamura H. I., Hruby V. J. Topographical requirements for delta opioid ligands: common structural features of dermenkephalin and deltorphin. Life Sci. 51:1992;1025-1032.
213. Misicka, A., Lipkowski, A. W., Nikiforovich, G. V., Kazmierski, W. M., Knapp, R. J., Yamamura, H. I. and Hruby, V. J. (1992) Computer modeling of opioid selective ligands: possible new topographical relationships to bioactivity are examined with new analogs designed for the δ opioid receptor. In: Peptides: Chemistry and Biology. Eds. J. Smith and J. E. Rivier.
214. Misicka, A., Lipkowski, A. W., Horvath, R., Davis, P., Yamamura, H. I., Porreca, F. and Hruby, V. J. (1993) Topographical requirements for d opioid ligands: the synthesis and biological properties of cyclic analogues of deltorphins and dermenkephalin. In: Peptides 1992, pp. 651-652. Eds. C. H. Schneider and A. N. Eberle. ESCOM Science.
215. Misicka A., Lipkowski A. W., Horvath R., Davis P., Yamamura H. I. Design of cyclic deltorphins and dermenkephalins with a disulfide bridge leads to analogues with high selectivity for δ-opioid receptors. J. Med. Chem. 37:1994;141-145.
216. 3 residues on peptide recognition for δ-opioid receptors. J. Pept. Res. 50:1997;48-54.
217. Miyamoto Y., Bowen W. D., Portoghese P. S., Takemori A. E. Lack of involvement of delta-1 opioid receptors in the development of physical dependence on morphine in mice. J. Pharmac. exp. Ther. 270:1994;37-39.
218. 2]deltorphin II-induced locomotor hyperactivity. Life Sci. 59:1996;69-73.
219. Mollay C., Vilas U., Hutticher A., Kreil G. Isolation of a dipeptidyl aminopeptidase, a putative processing enzyme, from skin secretion of Xenopus laevis. Eur. J. Biochem. 160:1986;31-35.
220. Mollay C., Wichta J., Kreil G. Detection and partial characterization of an amidating enzyme in skin secretion of Xenopus laevis. FEBS Lett. 202:1986;251-254.
221. Montecucchi P., De Castiglione R., Piani S., Gozzini L., Erspamer V. Amino acid composition and sequence of dermorphin a novel opiate-like peptide from the skin of Phyllomedusa sauvagei. Int. J. Pept. Prot. Res. 17:1981;275-283.
222. 6-dermorphin in skin extracts of the Brazilian frog Phyllomedusa rohdei. Int. J. Pept. Prot. Res. 17:1981;316-321.
223. Mor A., Delfour A., Sagan S., Amiche M., Pradelles P., Rossier J., Nicholas J. Isolation of dermenkephalin from amphibian skin, a high-affinity δ-selective opioid heptapeptide containing a D-amino acid residue. FEBS Lett. 225:1989;269-274.
224. Mor A., Delfour A., Nicolas P. Identification of a D-alanine containing polypeptide precursor for the peptide opioid dermorphin. J. Biol. Chem. 266:1991;6264-6270.
225. 2-opioid receptor selectivity. In: Medications Development: Drug Discovery, Databases, and Computer-aided Drug Design. Eds. R. Rapaka and R. Hawks, pp. 268-280. National Institute on Dug Abuse, Rockville, MD.
226. Mosberg H. I., Hurst R., Hruby V. J., Gee K., Yamamura H. I., Galligan J. J., Burks T. F. Bis-penicillamine enkephalins possess highly improved specificity toward δ opioid receptors. Proc. natl Acad. Sci. U.S.A. 80:1983;5871-8574.
227. Mosberg H. I., Omnass J. R., Sobczyk-Kojiro K., Dua R., Ho J. C., Ma W., Bush P., Mousigian C., Lomize A. Pharmacophore elements of the TIPP class of delta opioid receptor antagonists. Lett. Pept. Sci. 1:1994;69-72.
228. 5-enkephalin in cancer patients with chronic pain. Pain. 23:1985;213-221.
229. Naim M., Charpentier S., Nicholas P., Baron D. Quantitative two-dimensional NMR study of dermenkephalin, a highly potent and selective δ-opioid peptide. Biopolymers. 33:1993;1899-1900.
230. 2-opioid receptor agonist in the mouse spinal cord. Eur. J. Pharmac. 310:1996;R1-R3.
231. 2-opioid receptor agonist in the mouse spinal cord. Br. J. Pharmac. 120:1997;587-592.
232. Negri L., Noviello V., Angelucci F. Behavioural effects of deltorphins in rats. Eur. J. Pharmac. 209:1991;163-168.
233. Negri L., Potenza R. L., Corsi R., Melchiorri P. Evidence for two subtypes of δ opioid receptors in rat brain. Eur. J. Pharmac. 196:1991;335-336.
234. 4]deltorphin in supraspinal antinociception and δ-opioid receptor binding. Br. J. Pharmac. 116:1995;2931-2938.
235. Negri L., Severini C., Lattanzi R., Potenza R. L., Melchiorri P. Postnatal development of δ-opioid receptor subtypes in mice. Br. J. Pharmac. 120:1997;989-994.
236. Nevin S., Tóth G., Weltrowska G., Schiller P. W., Borsodi A. Synthesis and binding characteristics of tritiated TIPP[ψ], a highly specific and stable delta opioid antagonist. Life Sci. 56:1994;225-230.
237. 5,6deltorphin II. Neuropeptides. 26:1994;261-265.
238. Nikiforovich G., Hruby V. Examination of the conformational meaning of "δ-address" in the dermenkephalin sequence. Biochem. Biophys. Res. Commun. 173:1990;521-527.
239. Nikiforovich G., Prakash O., Gehrig C., Hruby V. Conformations of the dermenkephalin backbone in DMSO solution by a new approach to the solution conformations of flexible peptides. J. Am. Chem. Soc. 115:1992;3399-3406.
240. 2-opioid agonists in rat caudate putamen. J. Neurochem. 65:1995;125-133.
241. 2-opioid receptors activated by endogenous or exogenous opioid agonist on the endogenous cholecystokinn system: further evidence for δ-opioid receptor heterogeneity. Neuroscience. 75:1996;917-926.
242. 2]deltorphin-I-like immunoreactive structures in the rat brain. J. Comp. Neurol. 349:1994;223-243.
243. Noviello L., Papadia S., Capobianchi M. R., Negri L. Immunodulatory responses to δ-opioid receptor ligands in human lymphocytes. Eur. J. Pharmac. 332:1997;R1-R2.
244. Ohno Y., Segawa M., Ohishi H., Kitamura K., Ishida T., Inoue M., Iwashita T. Conformation of deltorphin-II in membrane environment studied by two dimensional NMR spectroscopy and molecular dynamics calculations. Eur. J. Biochem. 212:1993;185-191.
245. Olianas M., Onali P. Characterization of opioid receptors mediating stimulation of adenylate cyclase activity in rat olfactory bulb. Mol. Pharmac. 42:1992;109-115.
246. Olson G. A., Olson R. D., Kastin A. J. Endogenous opiates: 1996. Peptides. 18:1997;1651-1988.
247. Pak Y., O'Dowd B. F., George S. R. Agonist-induced desensitization of the μ opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal tail. J. Biol. Chem. 272:1997;24961-24965.
248. Pasternak G., Standifer K. Mapping of opioid receptors using antisense oligodeoxynucleotides: correlating their molecular biology and pharmacology. Trends Pharmac. Sci. 16:1995;344-350.
249. Pastore, A., Tancredi, T. and Temussi, P. A. (1985) Interpretation of the mu activity of several dermorphin fragments in terms of a new receptor model. In: Peptides: Structure and Function, pp. 529-532. Eds. C. M. Deber, V. J. Hruby and K. D. Kople. Pierce Chemical Company, Rockford, IL.
250. Patel D., McKinley B. D., Davis T. P., Porreca F., Yamamura H. I., Hruby V. J. Peptide targeting and delivery across the blood-brain barrier utilizing synthetic triglyceride esters: design, synthesis, and bioactivity. Bioconjugate Chem. 8:1997;434-441.
251. Pattabiraman N., Sorensen K. R., Langridge R., Bhatnagar R. S., Renugopalakrishnan V., Rapaka R. S. Molecular mechanics studies of dermorphin. Biochem. Biophys. Res. Commun. 140:1986;342-349.
252. Pavone F., Populin R., Castellano C., Kreil G., Melchiorri P. Deltorphin, a naturally occurring peptide with high selectivity for δ opioid receptors, improves memory consolidation in two inbred strains of mice. Peptides. 11:1990;591-594.
253. Paynter H., Sutton R., Mole E. J. Synthesis of deltorphin I analogues and preliminary characterisation of μ-receptor binding. Biochem. Soc. Trans. 21:1993;262S-263S.
254. Pei G., Kieffer B., Lefkowitz R., Freedman N. Agonist dependent phosphorylation of the mouse δ-opioid receptor: involvement of G protein coupled receptor kinases but not protein kinase C. Mol. Pharmac. 48:1995;173-177.
255. Pepin M.-C., Yue S. Y., Roberts E., Wahlestedt C., Walker P. Novel "restoration of function" mutagenesis strategy to identify amino acids of the δ-opioid receptor involved in ligand binding. J. Biol. Chem. 272:1997;9260-9267.
256. Pert C. B., Synder S. H. Properties of opiate receptor binding in rat brain. Proc. natl Acad. Sci. U.S.A. 70:1973;2243-2247.
257. Picone, D., Amodeo, P., Crescenzi, O., Temussi, P. A., Salvadori, S., Cavicchioni, G., Lazarus, L. H. and Tancredi, T. (1995) Conformational analysis of deltorphin I analogs containing alpha disubstituted residues in the message domain. In: Peptides 1994, pp. 630-631. Ed. H. L. S. Maia. ESCOM, Leiden.
258. Pogozheva, I. D., Lomize, A. L. and Mosberg, H. I. (1998) Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints. Biophys. J, 75, 612-634.
259. Polastron J., Jauzac P. Different subtypes of opioid receptors have different affinities for G-proteins. Cell. Mol. Biol. 40:1994;389-401.
260. 5]enkephalin after intracerebroventricular and intrathecal administration to mice. Life Sci. 33(Sup. I):1983;457-460.
261. Porreca, F., Takemori, A., Sultana, M., Portoghese, W., Bowen, W. and Mosberg, H. (1992) Modulation of mu-mediated antinociception in the mouse involves opioid delta-2-receptors. J. Pharmac. exp. Ther. 263, 147-152.
262. Portoghese P., Sultana M., Takemori A. Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist. Eur. J. Pharmac. 146:1988;185-186.
263. 1-opioid receptor antagonist: 7-benzylidenenaltrxone. Eur. J. Pharmac. 210:1992;195-196.
264. Prather P. L., McGinn T. M., Erickson L. J., Evans C. J., Loh H. H., Law P.-Y. Ability of δ-opioid receptors to interact with multiple G-proteins is independent of receptor density. J. Biol. Chem. 269:1994;21293-21302.
265. Prigge S. T., Kolhekar A. S., Eipper B. A., Mains R. E., Amzel L. M. Amidation of bioactive peptides: the structure of peptidylglycine α-hydroxylating monooxygenase. Science. 278:1997;1300-1305.
266. Qian X., Kover K. E., Shenderovich M. D., Lou B.-S., Misicka A., Zalewska T., Horvath R., Davis P., Bilsky E. J., Porreca F., Yamamura H. I., Hruby V. J. Newly discovered stereochemical requirements in the side-chain conformation of δ opioid agonists for recognizing opioid δ receptors. J. Med. Chem. 37:1994;1746-1757.
267. 5] enkephalin, in the μ-opioid receptor deficient CXBK mouse. Eur. J. Pharmac. 216:1992;453-4456.
268. Rapaka R. S., Porreca F. Development of delta opioid peptides as nonaddictive analgesics. Pharmac. Res. 8:1991;1-8.
269. 2]-deltorphin-I binding sites in the rat brain. NeuroReport. 4:1993;1143-1146.
270. Richter K., Egger R., Kreil G. D-Alanine in the frog skin peptide dermorphin is derived from L-alanine in the precursor. Science. 238:1987;200-202.
271. 2]deltorphin precursors from skin of Phyllomedusa bicolor also contain genetic information for three dermorphin-related opioid peptides. Proc. natl Acad. Sci. U.S.A. 87:1990;4836-4839.
272. 2-opioid receptor subtype stimulates phosphoinositide metabolism in mouse periaqueductal gray matter. Life Sci. 62, 253-258.
273. Romer, A. S. (1955) The Vertebrate Body. Saunders, Philadelphia.
274. Roques B. P., Gacel G., Fournie-Zaluski M.-C., Senault B., Lecomte J.-M. Demonstration of the crucial role of the phenylalanine moiety in enkephalin analogues for differential recognition of the μ- and δ-receptors. Eur. J. Pharmac. 60:1979;109-110.
275. Roseghini M., Erspamer G., Severini C. Biogenic amines and active peptides in the skin of fifty-two African amphibian species other than bufonids. Comp. Biochem. Physiol. 91C:1988;281-286.
276. Roseghini M., Falconieri Erspamer G., Severini C. Biogenic amines and active peptides in the skin of fifty-two African amphibian species other than bufonids. Comp. Biochem. Physiol. 91C:1988;281-286.
277. Roseghini M., Erspamer G., Severini C., Simmaco M. Biogenic amines and active peptides in extracts of the skin of thirty-two European amphibian species. Comp. Biochem. Physiol. 94C:1989;455-460.
278. Rossi G. C., Su W., Leventhal L., Su H., Pasternak G. W. Antisense mapping DOR-1 in mice: further support for δ receptor subtypes. Brain Res. 753:1997;176-179.
279. Rothman R., Danks J., Iadarola M. Unexpectedly high levels of opioid peptides in rat brain membranes. Peptides. 8:1986;645-649.
280. Ruegg H., Yu W.-Z., Bodnar R. J. Opioid-receptor subtype agonist-induced enhancements of sucrose intake are dependent upon sucrose concentration. Physiol. Behav. 62:1997;121-128.
281. Sagan S., Amiche M., Delfour A., Mor A., Camus A., Nicolas P. Differential contribution of C-terminal regions of dermorphin and dermenkephalin to opioid-sites selection and binding potency. Biochem. Biophys. Res. Commun. 163:1989;726-732.
282. Sagan S., Amiche M., Delfour A., Mor A., Camus A., Nicolas P. Molecular determinants of receptor affinity and selectivity of the natural Δ-opioid agonist, dermenkephalin. J. Biol. Chem. 264:1989;17100-17106.
283. Sagan S., Charpentier S., Delfour A., Amiche A., Nicolas P. The aspartic acid in deltorphin I and dermenkephalin promotes targeting to δ-opioid receptor independently of receptor binding. Biochem. Biophys. Res. Commun. 187:1992;1203-1210.
284. Salvadori S., Sarto G., Tomatis R. Synthesis and pharmacological activity of dermorphin and its N-terminal sequences. Int. J. Pept. Prot. Res. 19:1982;536-542.
285. 4]dermorphin-tetrapeptide analogues. Hoppe-Seyler's Z. Physiol. Chem. 365:1984;1199-1206.
286. Salvadori S., Marastoni M., Balboni G., Sarto G., Tomatis R. Synthesis and opioid activity of dermorphin tetrapeptides bearing D-methionine S-oxide at position 2. J. Med. Chem. 29:1986;889-894.
287. Salvadori S., Marastoni M., Balboni G., Borea P. A., Morai M., Tomatis R. Synthesis and structure-activity relationships of deltorphin analogues. J. Med. Chem. 34:1991;1656-1661.
288. 3 deltorphin analogues: enhanced selectivity of halogenated derivatives for δ opioid receptor sites. J. Med. Chem. 35:1992;4651-4657.
289. Salvadori et al. (1992b).
290. 3-Substituted analogues of deltorphin C. Spatial conformation and topography of the aromatic ring in peptide recognition by δ opioid receptors. J. Med. Chem. 36:1993;3748-3756.
291. 4]deltorphin C analogues: novel probes for the δ-opioid receptor. Eur. J. Pharmac. 230:1993;357-361.
292. Salvadori, S., Tomatis, R., Balboni, G., Marchetti, P., D'Angeli, F. and Lazarus, L H. (1993c) 2-Aminoamides and pseudopeptides carrying an amino group common to two residues. In: Peptides 1992, pp. 185-186. Eds. C. H. Schneider and A. N. Eberle. ESCOM Science.
293. 4 in deltorphin A for high δ opioid receptor selectivity. Amino Acids. 7:1994;291-304.
294. Salvadori S., Attila M., Balboni G., Bianchi C., Bryant S. D., Crescenzi O., Guerrini R., Picone D., Tancredi T., Temussi P. A., Lazarus L. H. δ Opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides. Mol. Med. 1:1995;678-689.
295. Salvadori S., Balboni G., Guerrini R., Tomatis R., Bianchi C., Bryant S. D., Cooper P. S., Lazarus L. H. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary δ opioid antagonist activity. J. Med. Chem. 42:1997;3100-3108.
296. Samii A., Bickel U., Stroth U., Pardridge W. M. Blood-brain barrier transport of neuropeptides: analysis with a metabolically stable dermorphin analogue. Am. J. Physiol. 267:1994;E124-E131.
297. i3 transducer proteins. Life Sci. 53:1993;PL129-134.
298. Sanchez-Blazquez P., Garzon J. Delta opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception. J. Pharac. exp. Ther. 285:1998;820-827.
299. i2 Transducer proteins on μ/δ opioid-mediated supraspinal antinociception. Life Sci. 53:1993;PL381-386.
300. Sargent D., Schwyzer R. Membrane lipid phase as catalyst for peptide-receptor interactions. Proc. natl Acad. Sci. U.S.A. 83:1986;5774-5778.
301. Sargent D., Bean J., Kosterlitz H., Schwyzer R. Cation dependence of opioid receptor binding supports theory on membrane-mediated receptor selectivity. Biochemistry. 27:1988;4974-4977.
302. Sasaki Y., Chiba T. Novel deltorphin heptapeptide analogs with potent δ agonist, δ antagonist, or mixed μ antagonist/δ agonist properties. J. Med. Chem. 38:1995;3995-3999.
303. 2]Deltorphin II analogs with high affinity and selectivity for delta-opioid receptor. Biochem. Biophys. Res. Commun. 180:1991;822-827.
304. 2] deltorphin II analogs. Chem. Pharmac. Bull. 41:1993;1391-1394.
305. Sasaki Y., Chiba T., Ambo A., Suzuki K. Degradation of deltorphins and their analogs by rat brain synaptosomal peptidases. Chem. Pharmac. Bull. 42:1994;592-594.
306. Schiller P., Nguyen T., Lemieux C., Maziak L. Synthesis and activity profiles of novel cyclic opioid peptide monomers and dimers. J. Med. Chem. 28:1985;1766-1771.
307. Schiller P., Nguyen T., Masiak L., Wilkes B., Lemieux C. Structure-activity relationships of cyclic opioid peptide analogues containing a phenylalanine residue in the 3-position. J. Med. Chem. 30:1987;2094-2099.
308. 2]deltorphin I analogs with extraordinary delta receptor activity. In: New Leads in Opioid Research, pp. 288-290. Eds. J. M. V. Ree, A. H. Mulder, V. M. Wiegant and T. B. V. W. Greidanus. Exerta Medica, Amsterdam.
309. Schiller P. W., Weltrowska C., Nguyen T. M.-D., Lemieux C., Chung N. N., Marsden B. J., Wilkes B. C. Conformational restriction of the phenylalanine residue in a cyclic peptide analogue: effects of receptor selectivity and stereospecificity. J. Med. Chem. 34:1991;3125-3132.
310. Schiller P. W., Nguyen T. M.-D., Weltrowska G., Wilkes B. C., Marsden J., Lemieux C., Chung N. N. Differential stereochemical requirements of μ vs. δ opioid receptors for ligand binding and signal transduction: development of a class of potent and highly δ-selective peptide antagonists. Proc. natl Acad. Sci. U.S.A. 89:1992;11871-11875.
311. Schiller P. W., Weltrowska G., Nguyen T. M.-D., Wilkes B. C., Chung N. N., Lemieux C. Conformationally restricted deltorphin analogues. J. Med. Chem. 35:1992;3956-3961.
312. Schiller P. W., Weltrowska G., Nguyen T. M.-D., Wilkes B. C., Chung N. N., Lemieux C. TIPP[ψ]: a highly potent and stable pseudopeptide δ opioid receptor antagonist with extraordinary δ selectivity. J. Med. Chem. 36:1993;3182-3187.
313. Schiller, P. W., Nguyen, T. M.-D., Weltrowska, G., Wilkes, B. C., Marsden, B. J., Schmidt, R., Lemieux, C. and Chung, N. N. (1994) TIPP opioid peptides: development of extraordinarily potent and selective δ antagonists and observation of astonishing structure-intrinsic activity relationships. In: Peptides: Chemistry and Biology, pp. 483-486. Eds. R. S. Hodges and J. A. Smith. ESCOM.
314. 2-Substitution in dermorphin, deltorphin I and dynorphin A analogs: effect on opioid receptor binding and opioid activity in vitro. Reg. Peptides. 54:1994;259-260.
315. 2]deltorphin I: effects on opioid receptor affinities and activities in vitro and on antinociceptive potency. Peptides. 18:1997;1615-1621.
316. 4 side chains: a report of 32 new analogues and a QSAR study. Bioorg. Med. Chem. 5:1997;2221-2234.
317. Schulz S., Schreff M., Koch T., Zimprich A., Gramsch C., Elde R., Hollt V. Immunolocalization of two mu-opioid receptor isoforms (MOR 1 and MOR 1B) in the rat central nervous system. Neuroscience. 82:1998;613-622.
318. Schwyzer R. Estimated conformation, orientation, and accumulation of dynorphin A-(1-13)-tridecapeptide on the surface of neutral lipid membranes. Biochemistry. 25:1986;4281-4286.
319. Schwyzer R. Molecular mechanism of opioid selection. Biochemistry. 25:1986;6335-6342.
320. Schwyzer R. Estimated membrane structure and receptor subtype selection of an opioid alkaloid peptide hybrid. Int. J. Pept. Prot. Res. 32:1988;476-483.
321. Scrutton N. S., Raine A. R. C. Cation-π bonding and amino-aromatic interactions in the bimolecular recognition of substituted ammonium ligands. J. Biochem. 319:1996;1-8.
322. Sedqi M., Roy S., Ramakrishnan S., Loh H. Expression cloning of a full length cDNA encoding delta opioid receptor from mouse thymocytes. J. Neuroimmun. 65:1996;167-170.
323. 1H-NMR spectroscopy. Int. J. Pept. Prot. Res. 44:1994;295-304.
324. Seki, T., Minami, M., Nakagawa, T., Ienaga, Y., Morisada, A. and Satoh, M. (1998) DAMGO recognizes four residues in the third extracellular loop to discriminate between μ- and κ-opioid receptors. Eur. J. Pharmac. 350, 301-310.
325. Shah, S., Duttaroy, A., Sehba, F., Chen, B., Phillipe J., Monderson, T., Lau-Cam, C., Carroll, J. and Yoburn, B. C. (1997) The effect of ethanol drinking on opioid analgesia and receptors in mice. Alcohol 14, 361-366.
326. 5]enkephalin, a peptide with extraordinary selectivity for δ-opioid receptors. J. Org. Chem. 56:1991;4981-4983.
327. Sharp B. M., Shahabi N., McKean D., Li M. D., McAllen K. Detection of basal levels and induction of delta opioid receptor mRNA in murine splenocytes. J. Neuroimmun. 78:1997;198-202.
328. Sharp, B., Gekker, G., Li, M. D., Chao, C. C. and Peterson, P. K. (1998) δ-Opioid suppression of human immunodeficiency virus-1 expression in T cells (Jurkat). Biochem. J. 56, 289-292.
329. Shen, J., Chan, K. W., Chen, B. T., Philippe, J., Sehba, F., Duttaroy, A., Carroll, J. and Yoburn, B. C. (1997) The effect of in vivo ethanol consumption on cyclic AMP and δ-opioid receptors in mouse striatum. Brain Res. 770, 65-71.
330. Shimomura K., Kamata O., Ueki S., Ida S., Oguri K., Yoshimura H., Tsukamoto H. Analgesic effect of morphine glucuronides. Tohoku J. Exp. Med. 105:1971;45-52.
331. 3H methionine enkephalin, an opioid peptide. Eur. J. Pharmac. 47:1978;319-331.
332. Sivanandaiah K. M., Babu V. V. S., Renukeshwar H. C., Lakshmana M., Babu R. Synthetic peptides related to the δ-receptor agonist, dermorphin gene associated peptide. Indian J. Biochem. Biophys. 32:1995;196-199.
333. Sofuoglu M., Portoghese P., Takemori A. Cross-tolerance studies in the spinal cord of β-FNA-treated mice provides other evidence for delta opioid receptor subtypes. Pharmac. Lett. 49:1991;PL153-PL156.
334. Sofuoglu M., Portoghese P., Takemori A. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes. J. Pharmac. exp. Ther. 257:1991;676-680.
335. Spanagel R., Herz A., Shippenberg T. S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. natl Acad. Sci. U.S.A. 89:1992;2046-2050.
336. Spetea M., Darula Z., Tóth G., Borsodi A. Synthesis and binding characteristics of the highly selective radiolablelled deltorphin analogues containing 2-aminotetralin-2-carboxylic acid in position 3. Neuropeptides. 31:1997;483-488.
337. Standifer K. M., Pasternak G. W. G proteins and opioid receptor-mediated signaling. Cell Signal. 9:1997;237-248.
338. 2]Deltrophin I binding and pharmacological evidence for a special subtype of δ-opioid receptor on human and invertebrate immune cells. Proc. natl. Acad. Sci. U.S.A. 89, 9316-9320.
339. 2-opioid receptor subtype on human vascular endothelium uncouples morphine stimulated nitric oxide release. Int. J. Cardiol. 64, S43-S51.
340. Stein C., Hassan A. H. S., Przewlocki R., Gamsch C., Peter K., Herz A. Opioids from immunocyctes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc. natl Acad. Sci. U.S.A. 87:1990;5935-5939.
341. Stevens C. W. Relative analgesic potency of mu, delta and kappa opioids after spinal administration in amphibians. J. Pharmac. exp. Ther. 276:1996;440-448.
342. 4]deltorphin. J. Pharmac. exp. Ther. 266:1993;820-827.
343. 2 agonists and is necessary for spinal adrenergic-opioid synergy. J. Neurosci. 17:1997;7157-7165.
344. Strader C. D., Fong T. M., Tota M. R. F. D. R. A. Structure and function of G protein-coupled receptors. A. Rev. Biochem. 63:1994;101-132.
345. Strahs D., Weinstein H. Comparative modeling and molecular dynamics studies of the δ, κ and μ opioid receptors. Prot. Engineer. 10:1997;1019-1038.
346. Surratt C., Johnson P., Moriwaki A., Seidleck B., Blaschak C., Wang J., Uhl G. μ Opiate receptor: charged transmembrane domain amino acids are critical for agonist recognition and intrinsic activity. J. Biol. Chem. 269:1994;20548-20553.
347. Suzuki T., Yoshiike M., Mizoguchi H., Kamei J., Misawa M., Nagase H. Blockage of δ-opioid receptors prevents morphine-induced place preference in mice. Jpn. J. Pharmac. 6:1994;131-137.
348. Suzuki T., Ikeda H., Tsuji M., Misawa M., Narita M., Tseng L. F. Antisense oligodeoxynucleotide to δ opioid receptors attenuates morphine dependence in mice. Life Sci. 61:1997;PL165-170.
349. Suzuki T., Mori T., Tsuji M., Maeda J., Kishimoto Y., Misawa M., Nagase H. Differential effects of μ-, δ- and κ-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats. Eur. J. Pharmac. 324:1997;21-29.
350. Suzuki T., Tsuji M., Ikeda H., Misawa M., Narita M., Tseng L. F. Antisense oligodeoxynucleotide to δ opioid receptors blocks cocaine-induced place preference in mice. Life Sci. 60:1997;PL283-288.
351. 35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects. J. Pharmac. exp. Ther. 283:1997;1276-1284.
352. 2-opioid receptors in the brain and spinal cord, respectively. Eur. J. Pharmac. 242:1993;145-150.
353. Tancredi T., Temussi P., Picone D., Amodeo P., Tomatis R., Salvadori S., Marastoni M., Santagada V., Balboni G. New insights on μ/δ selectivity of opioid peptides: conformational analysis of deltorphin analogues. Biopolymers. 31:1991;751-760.
354. Tancredi T., Salvadori S., Amodeo P., Picone D., Lazarus L. H., Bryant S. D., Guerrini R., Marzola G., Temussi P. A. Conversion of enkephalin and dermorphin into δ-selective opioid antagonists by single-residue substitution. Eur. J. Biochem. 224:1994;221-247.
355. Tang T., Kiang J. G., Cox B. M. Opioids acting through delta receptors elicit a transient increase in the intracellular free calcium concentration in dorsal root ganglion-neuroblastoma hybrid ND8-47 cells. J. Pharmac. exp. Ther. 270:1994;40-46.
356. 5]-enkephalin and neurotensin content in the rat. Biochem. Pharmac. 41:1991;1345.
357. Temussi P., Picone D., Tancredi T., Tomatis R., Salvadori S., Marastoni M., Balboni G. Conformational propertied of deltorphin: new features of the δ-opioid receptor. FEBS Lett. 247:1989;283-288.
358. Temussi P. A., Salvadori S., Amodeo P., Bianchi C., Guerrini R., Tomatis R., Lazarus L. H., Tancredi T. Selective opioid dipeptides. Biochem. Biophys. Res. Commun. 198:1994;933-939.
359. Teschemacher H., Kock G., Scheffler H., Hildebrand A., Brantl V. Opioid peptides. Immunological significance? Ann. N. Y. Acad. Sci. 594:1990;66-77.
360. Thomas A. W., Kavaliers M., Prato F. S., Ossenkopp K.-P. Pulsed magnetic field induced "analgesia" in the land snail, Cepaea nemoralis, and the effects of μ, δ, and κ opioid receptor agonists/antagonists. Peptides. 18:1997;703-709.
361. 2]deltorphin I and II analogues; in vitro blood-brain barrier permeability and stability. J. Pharmac. exp. Ther. 281:1997;817-825.
362. Thorat S. N., Hammond D. L. Modulation of nociception by microinjection of delta-1 and delta-2 opioid receptor ligands in the ventromedial medulla of the rat. J. Pharmac. exp. Ther. 283:1997;1185-1192.
363. Tomatis R., Marastoni M., Balboni G., Guerrini R., Capasso A., Sorrentino L., Santagada V., Caliendo G., Lazarus L. H., Salvadori S. Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides. J. Med. Chem. 40:1997;2948-2952.
364. 2] Deltorphin I-like immunoreactivity in the adult rat brain: immunohistochemical localization. Proc. natl Acad. Sci. U.S.A. 90:1993;9635-9639.
365. 2 with Replacement of Phe by βMePhe. ESCOM, Leiden. Peptides 1994, pp. 335-336. Ed Maida, H. L. S.
366. Tóth G., Darula Z., Peter A., Fulop F., Tourwé D., Jaspers H., Verheyden P., Bocskey Z., Tóth Z., Borsodi A. Conformationally constrained deltorphin analogues with 2-aminotetralin-2-carboxylic acid in position 3. J. Med. Chem. 40:1997;990-995.
367. 2-Dmt-Tic-OH, a new tritiated delta selective opioid dipeptide antagonist: synthesis and binding characteristics. FEBS Lett. submitted.
368. Tourwé D., Verschueren K., Frycia A., Davis P., Porreca F., Hruby V., Tóth G., Jaspers H., Verheyden P., van Binst G. Conformational restriction of Tyr and Phe side chain in opioid peptides: information about preferred and bioactive side-chain topology. Biopolymers. 38:1996;1-12.
369. Trapaidze N., Keith D. E., Cvejic S., Evans C. J., Devi L. A. Sequestration of the δ opioid receptor. Role of the C terminus in agonist-mediated internalization. J. Biol. Chem. 271:1996;29279-29285.
370. Traynor J. R. Opioid receptors and their subtypes: focus on peripheral isolated tissue preparations. Neurochem. Int. 24:1994;427-432.
371. Tseng L., Collins K., Kampine J. Antisense oligodeoxynucleotides to a δ-opioid receptor selectivity blocks the spinal antinociception induced by δ-, but not μ- or κ-opioid receptor agonists in the mouse. Eur. J. Pharmac. 258:1994;R1-R3.
372. 1-, μ-, or κ-opioid receptors are involved in te tail-flick inhibition induced by β-endorphin from nucleus raphe obscurus in the pentobarbital-anesthetized rat. Eur. J. Pharmac. 277:1995;251-256.
373. Tseng L. F., Narita M., Mizoguchi H., Kawai K., Mizusuna A., Kamei J., Suzuki T., Nagase H. Delta-1 opioid receptor-mediated antinociceptive properties of nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord. J. Pharmac. exp. Ther. 280:1997;600-605.
374. degli Uberti E. C., Salvadori S., Trasforini G., Margutti A., Ambrosio M. R., Portaluppi F., Vergnani L., Pansini R. δ-Opioid receptors and the secretion of growth hormone in man: effect of opioid δ-receptor agonist. Neuroendocrinology. 56:1992;907-912.
375. degli Uberti E. C., Salvadori S., Trasforini G., Marrgutti A., Ambrosio M., Rossi R., Portaluppi F., Pansini R. Effect of deltorphin on pituitary-adrenal response to insulin-induced hypoglycemia and ovine corticotropin-releasing hormone in healthy man. J. Clin. Endocrin. Metab. 75:1992;370-374.
376. degli Uberti E. C., Ambrosio M. R. L. V., Portaluppi F., Bondanelli M., Trasforini G., Margutti A., Salvadori S. Stress-induced activation of sympathetic nervous system is attenuated by the δ-opioid receptor agonist deltorphin in healthy man. J. Clin. Endocrinol. Metab. 77:1993;1490-1494.
377. Ueda H., Nozaki M., Satoh M. Multiple opioid receptors and GTP binding proteins. Comp. Biochem. Physiol. 98C:1991;157-169.
378. Ukai M., Holzman S. G. Effects of intrahypothalamic administration of opioid peptides selective for μ-, κ-, and δ-receptors on different schedules of water uptake in the rat. Brain Res. 459:1988;275-281.
379. 2-opioid receptors produces amnesia in mice. Eur. J. Pharmac. 338:1997;1-6.
380. Valeri P., Morrone L., Romanelli L. Manifestations of acute opiate withdrawal contracture in rabbit jejunum after μ-, κ-, and δ-receptor agonist exposure. Br. J. Pharmac. 106:1992;39-44.
381. Valiquette M., Vu H. K., Yue S. Y., Wahlestedt C., Walker P. Involvement of Trp-284, Val-296, and Val-297 of the human δ-opioid receptor in binding of δ-selective ligands. J. Biol. Chem. 271:1996;18789-18796.
382. Varga E., Li X., Stropova D., Zalewska T., Landsman R., Knapp R., Malatynska E., Kawai K., Mizusura A., Nagase H., Caldron S., Rice K., Hruby V., Roeske W., Yamamura H. The third extracellular loop of the human δ-opioid receptor determines the selectivity of δ-opioid agonists. Mol. Pharmac. 50:1996;1619-1624.
383. Vaughn L. K., Wire W. S., Davis P., Shimohigashi Y., Tóth G., Knapp R. J., Hruby V. J., Burks T. F., Yamamura H. I. Differentiation between rat brain and mouse vas deferens δ opioid receptors. Eur. J. Pharmac. 177:1990;99-101.
384. Wang J., Imam Y., Applier C., Gregor P., Spivak C., Uhl G. μ Opioid receptor: cDNA cloning and expression. Proc. natl Acad. Sci. U.S.A. 90:1993;10230-10234.
385. Wang W., Shahrestanifar M., Jin J., Howells R. Studies on μ and δ opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. Proc. natl Acad. Sci. U.S.A. 92:1995;12436-12440.
386. Wang H. Q., Kampine J. P., Tseng L. F. Antisense oligodeoxynucleotide to a δ-opioid receptor messenger RNA selectively blocks the antinociception induced by intracerebroventricularly administered δ- but not μ-, ε-, or κ-opioid receptor agonists in the mouse. Neuroscience. 75:1996;445-452.
387. 2) in modulating responses of nociceptive neurons in the superficial and deeper dorsal horn of the medulla (trigeminal nucleus caudalis) in the rat. Brain Res. 739:1996;235-243.
388. Wang, C., Zhou, D., Cheng, Z., Wei, Q., Chen, J., Li, G., Pei, G. and Chi, Z. (1998) The C-truncated δ-opioid receptor underwent agonist-dependent activation and desensitization. Biochem. Biophys. Res. Commun. 249, 321-324.
389. Watson G. B., Lanthorn T. H. Electrophysiological actions of delta opioids on CA1 of the rat hippocampal slice are mediated by one delta receptor subtype. Brain Res. 601:1993;129-135.
390. Wechselberger, C., Severini, C., Kreil, G. and Negri, L. (1998) A new opioid peptide predicted from clone cDNAs from skin of Pachymedusa daenicolor and Agalychinis annae. FEBS Lett. 429,41-43.
391. Whittaker V. P., Michaelson I. A., Kirkland R. J. The separation of synaptic vesicles from nerve-ending particles ('synaptosomes'). Biochem. J. 90:1964;293-303.
392. Wild K., Vanderah T., Mosberg H., Porreca F. Opioid δ receptor subtypes are associated with different potassium channels. Eur. J. Pharmac. 193:1991;135-136.
393. 4 substituted derivative to δ-opioid receptors. Eur. J. Pharmac. 246:1993;25-31.
394. Xu H., Ni Q., Jacobson A., Rice K., Rothman R. Preliminary ligand binding data for subtypes of the delta opioid receptor in rat brain membranes. Life Sci. 49:1991;PL141-PL146.
395. ncx binding sites in rat brain: further evidence for heterogeneity. Peptides. 13:1992;1207-1213.
396. nex binding sites in mouse brain: further evidence for δ receptor heterogeneity. Peptides. 14:1993;893-907.
397. Xue J., Chen C., Zhu J., Kunapuli S., de Riel K., Yu L., Lui-Chen L. The third extracellular loop of the μ opioid receptor is important for agonist selectivity. J. Biol. Chem. 270:1995;12977-12979.
398. Yajima H., Funakoshi S., Akaji K. Current contributions of peptide synthesis to studies on brain-gut-skin triangle peptides. Int. J. Pept. Prot. Res. 26:1985;337-361.
399. Yakovlev A. G., Krueger K., Faden A. Structure and expression of a rat κ opioid receptor gene. J. Biol. Chem. 270:1995;6421-6424.
400. Yamazaki T., Ro S., Goodman M., Chung N., Schiller P. A topographical approach to explain morphiceptin bioactivity. J. Med. Chem. 36:1993;708-719.
401. Yoshida M., Yokoo H., Tanaka T., Mizoguchi K., Emoto H., Ishii H., Tanaka M. Facilitatory modulation of mesolimibic dopamine neuronal activity by a μ-opioid agonist and nicotine as examined with in vivo microdialysis. Brain Res. 624:1993;277-280.
402. Yu W.-Z., Bodnar R. J. Interactions between angiotensin II and delta opioid receptor subtype agonists upon water intake in rats. Peptides. 18:1997;241-245.
403. Yu W.-Z., Ruegg H., Bodnar R. J. Delta and kappa opioid receptor subtypes and ingestion: antagonist and glucorivic effects. Pharmac. Biochem. Behav. 56:1997;353-361.
404. Zaki P. A., Bilsky E. J., Vanderah T. W., Lai J., Evans C. J., Porreca F. Opioid receptor types and subtypes: the δ receptor as a model. A. Rev. Pharmac. Toxic. 36:1996;379-401.
405. 2-opioid receptor agonist in mice. Peptides. 17:1996;619-623.
406. 4]deltorphin II on tolerance to their analgesic action and on brain δ-opioid receptors. Brain Res. 745:1997;243-247.
407. Zhao J., Pei G., Huang Y.-L., Zhong F.-M., Ma L. Carboxyl terminus of delta opioid receptor is required for agonist-dependent receptor phosphorylation. Biochem. Biophys. Res. Commun. 238:1997;71-76.
408. Zimprich A., Simon T., Hollt V. Cloning and expression of an isoform of the rat μ opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1. FEBS Lett. 359:1995;142-146.